Document:

Exhibit 10.130

 

EXHIBIT F

 

 

SUBSIDIARY GUARANTEE

 

SUBSIDIARY GUARANTEE,
dated as of March __, 2017 (this “Guarantee”), made by each of the signatories hereto (together with any other
entity that may become a party hereto as provided herein, the “Guarantors”), in favor of the purchasers and
investors, as applicable, signatory (together with their permitted assigns, the “Purchasers”) to that certain
Securities Purchase Agreement (“Purchase Agreement”), dated as of the date hereof, between Rennova Health, Inc.,
a Delaware corporation (the “Company”) and the purchasers and those certain Securities Exchange Agreements (“Exchange
Agreements”), dated as of the date hereof, by and between the Company and the investors signatory thereto.

 

W I T N E S S E T H:

 

WHEREAS, pursuant
to that certain Securities Purchase Agreement, dated as of the date hereof, by and between the Company and the purchasers signatory
thereto (the “Purchase Agreement”) and the Securities Exchange Agreement, dated as of the date hereof, by and
between the Company and the Investors signatory thereto, the Company has agreed to sell and issue to the Purchasers, and the Purchasers
have agreed to purchase from the Company the Debentures, subject to the terms and conditions set forth therein; and

 

WHEREAS, each Guarantor will directly benefit from the extension of credit to the Company
represented by the issuance of the Debentures; and

 

NOW, THEREFORE, in
consideration of the premises and to induce the Purchasers to enter into the Purchase Agreement and the Exchange Agreement and
to carry out the transactions contemplated thereby, each Guarantor hereby agrees with the Purchasers as follows:

 

1.              
Definitions. Unless otherwise defined herein, terms defined in the Purchase Agreement and the Exchange Agreement and used
herein shall have the meanings given to them in the Purchase Agreement and the Exchange Agreement. The words “hereof,”
“herein,” “hereto” and “hereunder” and words of similar import when used in this Guarantee
shall refer to this Guarantee as a whole and not to any particular provision of this Guarantee, and Section and Schedule references
are to this Guarantee unless otherwise specified. The meanings given to terms defined herein shall be equally applicable to both
the singular and plural forms of such terms. The following terms shall have the following meanings:

 

“Guarantee”
means this Subsidiary Guarantee, as the same may be amended, supplemented or otherwise modified from time to time.

 

 

 

 

    	 	1	 

     

    

 

“Obligations” means, in addition to all other costs and expenses of collection incurred by Purchasers in enforcing
any of such Obligations and/or this Guarantee, all of the liabilities and obligations (primary, secondary, direct, contingent,
sole, joint or several) due or to become due, or that are now or may be hereafter contracted or acquired, or owing to, of the
Company or any Guarantor to the Purchasers, including, without limitation, all obligations under this Guarantee, the Debentures
and any other instruments, agreements or other documents executed and/or delivered in connection herewith or therewith, in each
case, whether now or hereafter existing, voluntary or involuntary, direct or indirect, absolute or contingent, liquidated or unliquidated,
whether or not jointly owed with others, and whether or not from time to time decreased or extinguished and later increased, created
or incurred, and all or any portion of such obligations or liabilities that are paid, to the extent all or any part of such payment
is avoided or recovered directly or indirectly from any of the Purchasers as a preference, fraudulent transfer or otherwise as
such obligations may be amended, supplemented, converted, extended or modified from time to time. Without limiting the generality
of the foregoing, the term “Obligations” shall include, without limitation: (i) principal of, and interest on the
Debentures and the loans extended pursuant thereto; (ii) any and all other fees, indemnities, costs, obligations and liabilities
of the Company or any Guarantor from time to time under or in connection with this Guarantee, the Debentures and any other instruments,
agreements or other documents executed and/or delivered in connection herewith or therewith; and (iii) all amounts (including
but not limited to post-petition interest) in respect of the foregoing that would be payable but for the fact that the obligations
to pay such amounts are unenforceable or not allowable due to the existence of a bankruptcy, reorganization or similar proceeding
involving the Company or any Guarantor. Notwithstanding anything herein to the contrary, any liability or obligations relating
to a transaction that is not related, directly or indirectly to the Transaction Documents or any future loan facility shall not
be deemed an Obligation hereunder.

 

2.              
Guarantee.

 

(a)            
Guarantee.

 

(i)             
The Guarantors hereby, jointly and severally, unconditionally and irrevocably, guarantee to the Purchasers and their respective
successors, indorsees, transferees and assigns, the prompt and complete payment and performance when due (whether at the stated
maturity, by acceleration or otherwise) of the Obligations.

 

(ii)           
Anything herein or in any other Transaction Document to the contrary notwithstanding, the maximum liability of each Guarantor
hereunder and under the other Transaction Documents shall in no event exceed the amount which can be guaranteed by such Guarantor
under applicable federal and state laws, including laws relating to the insolvency of debtors, fraudulent conveyance or transfer
or laws affecting the rights of creditors generally (after giving effect to the right of contribution established in Section 2(b)).

 

(iii)         
Each Guarantor agrees that the Obligations may at any time and from time to time exceed the amount of the liability of such
Guarantor hereunder without impairing the guarantee contained in this Section 2 or affecting the rights and remedies of the Purchasers
hereunder.

 

(iv)          
The guarantee contained in this Section 2 shall remain in full force and effect until all the Obligations and the obligations
of each Guarantor under the guarantee contained in this Section 2 shall have been satisfied by indefeasible payment in full.

 

(v)            
No payment made by the Company, any of the Guarantors, any other guarantor or any other Person or received or collected
by the Purchasers from the Company, any of the Guarantors, any other guarantor or any other Person by virtue of any action or proceeding
or any set-off or appropriation or application at any time or from time to time in reduction of or in payment of the Obligations
shall be deemed to modify, reduce, release or otherwise affect the liability of any Guarantor hereunder which shall, notwithstanding
any such payment (other than any payment made by such Guarantor in respect of the Obligations or any payment received or collected
from such Guarantor in respect of the Obligations), remain liable for the Obligations up to the maximum liability of such Guarantor
hereunder until the Obligations are indefeasibly paid in full.

 

 

 

    	 	2	 

     

    

 

(vi)          
Notwithstanding anything to the contrary in this Guarantee, with respect to any defaulted non-monetary Obligations the specific
performance of which by the Guarantors is not reasonably possible (e.g. the issuance of the Company's Common Stock), the Guarantors
shall only be liable for making the Purchasers whole on a monetary basis for the Company's failure to perform such Obligations
in accordance with the Transaction Documents.

 

(b)            
Right of Contribution. Subject to Section 2(c), each Guarantor hereby agrees that to the extent that a Guarantor
shall have paid more than its proportionate share of any payment made hereunder, such Guarantor shall be entitled to seek and receive
contribution from and against any other Guarantor hereunder which has not paid its proportionate share of such payment. Each Guarantor's
right of contribution shall be subject to the terms and conditions of Section 2(c). The provisions of this Section 2(b) shall in
no respect limit the obligations and liabilities of any Guarantor to the Purchasers and each Guarantor shall remain liable to the
Purchasers for the full amount guaranteed by such Guarantor hereunder.

 

(c)            
No Subrogation. Notwithstanding any payment made by any Guarantor hereunder or any set-off or application of funds
of any Guarantor by the Purchasers, no Guarantor shall be entitled to be subrogated to any of the rights of the Purchasers against
the Company or any other Guarantor or any collateral security or guarantee or right of offset held by the Purchasers for the payment
of the Obligations, nor shall any Guarantor seek or be entitled to seek any contribution or reimbursement from the Company or any
other Guarantor in respect of payments made by such Guarantor hereunder, until all amounts owing to the Purchasers by the Company
on account of the Obligations are indefeasibly paid in full. If any amount shall be paid to any Guarantor on account of such subrogation
rights at any time when all of the Obligations shall not have been paid in full, such amount shall be held by such Guarantor in
trust for the Purchasers, segregated from other funds of such Guarantor, and shall, forthwith upon receipt by such Guarantor, be
turned over to the Purchasers in the exact form received by such Guarantor (duly indorsed by such Guarantor to the Purchasers,
if required), to be applied against the Obligations, whether matured or unmatured, in such order as the Purchasers may determine.

 

(d)            
Amendments, Etc. With Respect to the Obligations. Each Guarantor shall remain obligated hereunder notwithstanding
that, without any reservation of rights against any Guarantor and without notice to or further assent by any Guarantor, any demand
for payment of any of the Obligations made by the Purchasers may be rescinded by the Purchasers and any of the Obligations continued,
and the Obligations, or the liability of any other Person upon or for any part thereof, or any collateral security or guarantee
therefor or right of offset with respect thereto, may, from time to time, in whole or in part, be renewed, extended, amended, modified,
accelerated, compromised, waived, surrendered or released by the Purchasers, and the Purchase Agreement, Exchange Agreement and
the other Transaction Documents and any other documents executed and delivered in connection therewith may be amended, modified,
supplemented or terminated, in whole or in part, as the Purchasers may deem advisable from time to time, and any collateral security,
guarantee or right of offset at any time held by the Purchasers for the payment of the Obligations may be sold, exchanged, waived,
surrendered or released. The Purchasers shall have no obligation to protect, secure, perfect or insure any Lien at any time held
by them as security for the Obligations or for the guarantee contained in this Section 2 or any property subject thereto.

 

 

 

 

 

 

    	 	3	 

     

    

 

(e)             Guarantee
Absolute and Unconditional. Each Guarantor waives any and all notice of the creation, renewal, extension or accrual of
any of the Obligations and notice of or proof of reliance by the Purchasers upon the guarantee contained in this Section 2 or
acceptance of the guarantee contained in this Section 2; the Obligations, and any of them, shall conclusively be deemed to
have been created, contracted or incurred, or renewed, extended, amended or waived, in reliance upon the guarantee
contained in this Section 2; and all dealings between the Company and any of the Guarantors, on the one hand, and the
Purchasers, on the other hand, likewise shall be conclusively presumed to have been had or consummated in reliance upon the
guarantee contained in this Section 2. Each Guarantor waives to the extent permitted by law diligence, presentment, protest,
demand for payment and notice of default or nonpayment to or upon the Company or any of the Guarantors with respect to the
Obligations. Each Guarantor understands and agrees that the guarantee contained in this Section 2 shall be construed as a
continuing, absolute and unconditional guarantee of payment and performance without regard to (a) the validity or
enforceability of the Purchase Agreement, Exchange Agreement or any other Transaction Document, any of the Obligations or any
other collateral security therefor or guarantee or right of offset with respect thereto at any time or from time to time held
by the Purchasers, (b) any defense, set-off or counterclaim (other than a defense of payment or performance or fraud by
Purchasers) which may at any time be available to or be asserted by the Company or any other Person against the Purchasers,
or (c) any other circumstance whatsoever (with or without notice to or knowledge of the Company or such Guarantor) which
constitutes, or might be construed to constitute, an equitable or legal discharge of the Company for the Obligations, or of
such Guarantor under the guarantee contained in this Section 2, in bankruptcy or in any other instance. When making any
demand hereunder or otherwise pursuing its rights and remedies hereunder against any Guarantor, the Purchasers may, but shall
be under no obligation to, make a similar demand on or otherwise pursue such rights and remedies as they may have against the
Company, any other Guarantor or any other Person or against any collateral security or guarantee for the Obligations or any
right of offset with respect thereto, and any failure by the Purchasers to make any such demand, to pursue such other rights
or remedies or to collect any payments from the Company, any other Guarantor or any other Person or to realize upon any such
collateral security or guarantee or to exercise any such right of offset, or any release of the Company, any other Guarantor
or any other Person or any such collateral security, guarantee or right of offset, shall not relieve any Guarantor of any
obligation or liability hereunder, and shall not impair or affect the rights and remedies, whether express, implied or
available as a matter of law, of the Purchasers against any Guarantor. For the purposes hereof, “demand” shall
include the commencement and continuance of any legal proceedings.

 

(f)             
Reinstatement. The guarantee contained in this Section 2 shall continue to be effective, or be reinstated, as the
case may be, if at any time payment, or any part thereof, of any of the Obligations is rescinded or must otherwise be restored
or returned by the Purchasers upon the insolvency, bankruptcy, dissolution, liquidation or reorganization of the Company or any
Guarantor, or upon or as a result of the appointment of a receiver, intervenor or conservator of, or trustee or similar officer
for, the Company or any Guarantor or any substantial part of its property, or otherwise, all as though such payments had not been
made.

 

(g)            
Payments. Each Guarantor hereby guarantees that payments hereunder will be paid to the Purchasers without set-off
or counterclaim in U.S. dollars at the address set forth or referred to in the Signature Pages to the Purchase Agreement or the
Exchange Agreement, as applicable.

 

 

 

 

 

 

 

    	 	4	 

     

    

 

3.              
Representations and Warranties. Each Guarantor hereby makes the following representations and warranties to Purchasers as
of the date hereof:

 

(a)            
Organization and Qualification. The Guarantor is a corporation or other limited liability company, duly incorporated
or organized, validly existing and in good standing under the laws of the applicable jurisdiction set forth on Schedule 1, with
the requisite corporate or company power and authority to own and use its properties and assets and to carry on its business as
currently conducted. The Guarantor has no subsidiaries other than those identified as such on the Disclosure Schedules to the Purchase
Agreement. The Guarantor is duly qualified to do business and is in good standing as a foreign corporation or company in each jurisdiction
in which the nature of the business conducted or property owned by it makes such qualification necessary, except where the failure
to be so qualified or in good standing, as the case may be, could not, individually or in the aggregate, (x) adversely affect the
legality, validity or enforceability of any of this Guaranty in any material respect, (y) have a material adverse effect on the
results of operations, assets, prospects, or financial condition of the Guarantor or (z) adversely impair in any material respect
the Guarantor's ability to perform fully on a timely basis its obligations under this Guaranty (a “Material Adverse Effect”).

 

(b)            
Authorization; Enforcement. The Guarantor has the requisite corporate or other power and authority to enter into
and to consummate the transactions contemplated by this Guaranty, and otherwise to carry out its obligations hereunder. The execution
and delivery of this Guaranty by the Guarantor and the consummation by it of the transactions contemplated hereby have been duly
authorized by all requisite corporate or other action on the part of the Guarantor. This Guaranty has been duly executed and delivered
by the Guarantor and constitutes the valid and binding obligation of the Guarantor enforceable against the Guarantor in accordance
with its terms, except as such enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium,
liquidation or similar laws relating to, or affecting generally the enforcement of, creditors' rights and remedies or by other
equitable principles of general application.

 

(c)            
No Conflicts. The execution, delivery and performance of this Guaranty by the Guarantor and the consummation by the
Guarantor of the transactions contemplated thereby do not and will not (i) conflict with or violate any provision of its Certificate
of Incorporation, or By-laws, articles of organization or operating agreement or (ii) conflict with, constitute a default (or an
event which with notice or lapse of time or both would become a default) under, or give to others any rights of termination, amendment,
acceleration or cancellation of, any agreement, indenture or instrument to which the Guarantor is a party, or (iii) result in a
violation of any law, rule, regulation, order, judgment, injunction, decree or other restriction of any court or governmental authority
to which the Guarantor is subject (including Federal and State securities laws and regulations), or by which any material property
or asset of the Guarantor is bound or affected, except in the case of each of clauses (ii) and (iii), such conflicts, defaults,
terminations, amendments, accelerations, cancellations and violations as could not, individually or in the aggregate, have or result
in a Material Adverse Effect. The business of the Guarantor is not being conducted in violation of any law, ordinance or regulation
of any governmental authority, except for violations which, individually or in the aggregate, do not have a Material Adverse Effect.

 

(d)            
Consents and Approvals. The Guarantor is not required to obtain any consent, waiver, authorization or order of, or
make any filing or registration with, any court or other federal, state, local, foreign or other governmental authority or other
person in connection with the execution, delivery and performance by the Guarantor of this Guaranty.

 

 

 

 

    	 	5	 

     

    

 

(e)            
Purchase Agreement. The representations and warranties of the Company set forth in the Purchase Agreement and the
Exchange Agreement as they relate to such Guarantor, each of which is hereby incorporated herein by reference, are true and correct
as of each time such representations are deemed to be made pursuant to such Purchase Agreement and Exchange Agreement, and the
Purchasers shall be entitled to rely on each of them as if they were fully set forth herein, provided that each reference in each
such representation and warranty to the Company's knowledge shall, for the purposes of this Section 3, be deemed to be a reference
to such Guarantor's knowledge.

 

(f)             
Foreign Law. Each Guarantor has consulted with appropriate foreign legal counsel with respect to any of the above
representations for which non-U.S. law is applicable. Such foreign counsel have advised each applicable Guarantor that such counsel
knows of no reason why any of the above representations would not be true and accurate. Such foreign counsel were provided with
copies of this Subsidiary Guarantee and the Transaction Documents prior to rendering their advice.

 

4.              
Covenants.

 

(a)       
Each Guarantor covenants and agrees with the Purchasers that, from and after the date of this Guarantee until the Obligations
shall have been indefeasibly paid in full, such Guarantor shall take, and/or shall refrain from taking, as the case may be, each
commercially reasonable action that is necessary to be taken or not taken, as the case may be, so that no Event of Default (as
defined in the Debentures) is caused by the failure to take such action or to refrain from taking such action by such Guarantor.

 

(b)       
So long as any of the Obligations are outstanding, unless Purchasers holding at least 67% of the aggregate principal amount
of the then outstanding Debentures shall otherwise consent in writing, each Guarantor will not directly or indirectly on or after
the date of this Guarantee:

 

i.                   
enter into, create, incur, assume or suffer to exist any indebtedness in excess of $100,000 for borrowed money of any kind (other
than any indebtedness existing on the date hereof), including but not limited to, a guarantee, on or with respect to any of its
property or assets now owned or hereafter acquired or any interest therein or any income or profits therefrom;

 

ii.                   
enter into, create, incur, assume or suffer to exist any liens of any kind, on or with respect to any of its property or assets
now owned or hereafter acquired or any interest therein or any income or profits therefrom, except for any liens existing on the
date hereof;

 

iii.                   
amend its certificate of incorporation, bylaws or other charter documents so as to adversely affect any rights of any Purchaser;

 

iv.                   
repay, repurchase or offer to repay, repurchase or otherwise acquire more than a de minimis number of shares of its securities
or debt obligations except pursuant to their terms as such terms exist on the date hereof;

 

v.                   
pay cash dividends on any equity securities of the Company;

 

 

 

 

 

 

 

    	 	6	 

     

    

 

vi.                   
enter into any transaction with any Affiliate of the Guarantor which would be required to be disclosed in any public filing of
the Company with the Commission, unless such transaction is made on an arm’s-length basis and expressly approved by a majority
of the disinterested directors of the Company (even if less than a quorum otherwise required for board approval); or

 

vii.                   
enter into any agreement with respect to any of the foregoing.

 

5.              
Miscellaneous.

 

(a)            
Amendments in Writing. None of the terms or provisions of this Guarantee may be waived, amended, supplemented or
otherwise modified except in writing by the Purchasers.

 

(b)            
Notices. All notices, requests and demands to or upon the Purchasers or any Guarantor hereunder shall be effected
in the manner provided for in the Purchase Agreement or Exchange Agreement, as applicable, provided that any such notice, request
or demand to or upon any Guarantor shall be addressed to such Guarantor at its notice address set forth on Schedule 5(b).

 

(c)            
No Waiver By Course Of Conduct; Cumulative Remedies. The Purchasers shall not by any act (except by a written instrument
pursuant to Section 5(a)), delay, indulgence, omission or otherwise be deemed to have waived any right or remedy hereunder or to
have acquiesced in any default under the Transaction Documents or Event of Default. No failure to exercise, nor any delay in exercising,
on the part of the Purchasers, any right, power or privilege hereunder shall operate as a waiver thereof. No single or partial
exercise of any right, power or privilege hereunder shall preclude any other or further exercise thereof or the exercise of any
other right, power or privilege. A waiver by the Purchasers of any right or remedy hereunder on any one occasion shall not be construed
as a bar to any right or remedy which the Purchasers would otherwise have on any future occasion. The rights and remedies herein
provided are cumulative, may be exercised singly or concurrently and are not exclusive of any other rights or remedies provided
by law.

 

(d)            
Enforcement Expenses; Indemnification.

 

(i)             
Each Guarantor agrees to pay, or reimburse the Purchasers for, all its costs and expenses incurred in collecting against
such Guarantor under the guarantee contained in Section 2 or otherwise enforcing or preserving any rights under this Guarantee
and the other Transaction Documents to which such Guarantor is a party, including, without limitation, the reasonable fees and
disbursements of counsel to the Purchasers.

 

(ii)           
Each Guarantor agrees to pay, and to save the Purchasers harmless from, any and all liabilities with respect to, or resulting
from any delay in paying, any and all stamp, excise, sales or other taxes which may be payable or determined to be payable in connection
with any of the transactions contemplated by this Guarantee.

 

(iii)         
Each Guarantor agrees to pay, and to save the Purchasers harmless from, any and all liabilities, obligations, losses, damages,
penalties, actions, judgments, suits, costs, expenses or disbursements of any kind or nature whatsoever with respect to the execution,
delivery, enforcement, performance and administration of this Guarantee to the extent the Company would be required to do so pursuant
to the Purchase Agreement and Exchange Agreement.

 

 

 

 

    	 	7	 

     

    

 

(iv)          
The agreements in this Section shall survive repayment of the Obligations and all other amounts payable under the Purchase
Agreement, Exchange Agreement and the other Transaction Documents.

 

(e)            
Successor and Assigns. This Guarantee shall be binding upon the successors and assigns of each Guarantor and shall
inure to the benefit of the Purchasers and their respective successors and assigns; provided that no Guarantor may assign, transfer
or delegate any of its rights or obligations under this Guarantee without the prior written consent of the holders of the Obligations.

 

(f)             
Set-Off. Each Guarantor hereby irrevocably authorizes the Purchasers at any time and from time to time while an Event
of Default under any of the Transaction Documents shall have occurred and be continuing, without notice to such Guarantor or any
other Guarantor, any such notice being expressly waived by each Guarantor, to set-off and appropriate and apply any and all deposits,
credits, indebtedness or claims, in any currency, in each case whether direct or indirect, absolute or contingent, matured or unmatured,
at any time held or owing by the Purchasers to or for the credit or the account of such Guarantor, or any part thereof in such
amounts as the Purchasers may elect, against and on account of the obligations and liabilities of such Guarantor to the Purchasers
hereunder and claims of every nature and description of the Purchasers against such Guarantor, in any currency, whether arising
hereunder, under the Purchase Agreement, Exchange Agreement and any other Transaction Document or otherwise, as the Purchasers
may elect, whether or not the Purchasers have made any demand for payment and although such obligations, liabilities and claims
may be contingent or unmatured. The Purchasers shall notify such Guarantor promptly of any such set-off and the application made
by the Purchasers of the proceeds thereof, provided that the failure to give such notice shall not affect the validity of such
set-off and application. The rights of the Purchasers under this Section are in addition to other rights and remedies (including,
without limitation, other rights of set-off) which the Purchasers may have.

 

(g)            
Counterparts. This Guarantee may be executed by one or more of the parties to this Guarantee on any number of separate
counterparts (including by telecopy), and all of said counterparts taken together shall be deemed to constitute one and the same
instrument.

 

(h)            
Severability. Any provision of this Guarantee which is prohibited or unenforceable in any jurisdiction shall, as
to such jurisdiction, be ineffective to the extent of such prohibition or unenforceability without invalidating the remaining provisions
hereof, and any such prohibition or unenforceability in any jurisdiction shall not invalidate or render unenforceable such provision
in any other jurisdiction.

 

 

 

    	 	8	 

     

    

 

(i)             
Section Headings. The Section headings used in this Guarantee are for convenience of reference only and are not to
affect the construction hereof or be taken into consideration in the interpretation hereof.

 

(j)             
Integration. This Guarantee and the other Transaction Documents represent the agreement of the Guarantors and the
Purchasers with respect to the subject matter hereof and thereof, and there are no promises, undertakings, representations or warranties
by the Purchasers relative to the subject matter hereof and thereof not expressly set forth or referred to herein or in the other
Transaction Documents.

 

(k)            
Governing Laws. All questions concerning the construction, validity, enforcement and interpretation of this Guarantee
shall be governed by and construed and enforced in accordance with the internal laws of the State of New York, without regard to
the principles of conflicts of law thereof. Each of the Company and the Guarantors agree that all proceedings concerning the interpretations,
enforcement and defense of the transactions contemplated by this Guarantee (whether brought against a party hereto or its respective
affiliates, directors, officers, shareholders, partners, members, employees or agents) shall be commenced exclusively in the state
and federal courts sitting in the City of New York, Borough of Manhattan. Each of the Company and the Guarantors hereby irrevocably
submits to the exclusive jurisdiction of the state and federal courts sitting in the City of New York, Borough of Manhattan for
the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein,
and hereby irrevocably waives, and agrees not to assert in any proceeding, any claim that it is not personally subject to the jurisdiction
of any such court, that such proceeding is improper. Each party hereto hereby irrevocably waives personal service of process and
consents to process being served in any such proceeding by mailing a copy thereof via registered or certified mail or overnight
delivery (with evidence of delivery) to such party at the address in effect for notices to it under this Guarantee and agrees that
such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed
to limit in any way any right to serve process in any manner permitted by law. Each party hereto hereby irrevocably waives, to
the fullest extent permitted by applicable law, any and all right to trial by jury in any legal proceeding arising out of or relating
to this Guarantee or the transactions contemplated hereby.

 

(l)             
Acknowledgements. Each Guarantor hereby acknowledges that:

 

(i)             
it has been advised by counsel in the negotiation, execution and delivery of this Guarantee and the other Transaction Documents
to which it is a party;

 

(ii)           
the Purchasers have no fiduciary relationship with or duty to any Guarantor arising out of or in connection with this Guarantee
or any of the other Transaction Documents, and the relationship between the Guarantors, on the one hand, and the Purchasers, on
the other hand, in connection herewith or therewith is solely that of debtor and creditor; and

 

 

 

    	 	9	 

     

    

 

(iii)         
no joint venture is created hereby or by the other Transaction Documents or otherwise exists by virtue of the transactions
contemplated hereby among the Guarantors and the Purchasers.

 

(m)          
Additional Guarantors. The Company shall cause each of its subsidiaries formed or acquired on or subsequent to the
date hereof to become a Guarantor for all purposes of this Guarantee by executing and delivering an

Assumption Agreement in the form of Annex 1 hereto.

 

(n)            
Release of Guarantors. Each Guarantor will be released from all liability hereunder concurrently with the indefeasible
repayment in full of all amounts owed under the Purchase Agreement, the Exchange Agreement, the Debentures and the other Transaction
Documents.

 

(o)            
Seniority. The Obligations of each of the Guarantors hereunder rank senior in priority to any other Indebtedness
(as defined in the Purchase Agreement) of such Guarantor.

 

(p)            
WAIVER OF JURY TRIAL. EACH GUARANTOR AND, BY ACCEPTANCE OF THE BENEFITS HEREOF, THE PURCHASERS, HEREBY IRREVOCABLY
AND UNCONDITIONALLY WAIVE TRIAL BY JURY IN ANY LEGAL ACTION OR PROCEEDING RELATING TO THIS GUARANTEE AND FOR ANY COUNTERCLAIM THEREIN.

 

*********************

 

(Signature
Pages Follow)

 

 

 

 

 

 

 

    	 	10	 

     

    

 

IN WITNESS WHEREOF,
each of the undersigned has caused this Guarantee to be duly executed and delivered as of the date first above written.

 

 

[SUBSIDIARY]

 

By:_________________________________

Name:

Title:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    	 	11	 

     

    

 

SCHEDULE 1

 

GUARANTORS

 

The following are the names, notice addresses
and jurisdiction of organization of each Guarantor.

 

	 	JURISDICTION OF INCORPORATION	COMPANY OWNED BY PERCENTAGE
	 	 	 
	 	 	 
	 	 	 
	 	 	 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    	 	12	 

     

    

Annex 1 to

SUBSIDIARY GUARANTEE

 

ASSUMPTION AGREEMENT, dated as of ____
__, ______ made by ______________________________, a ______________ corporation (the “Additional Guarantor”),
in favor of the Purchasers pursuant to the agreements referred to below. All capitalized terms not defined herein shall have the
meaning ascribed to them in such agreements.

 

W I T N E S S E T
H :

 

WHEREAS,
Rennova Health, Inc., a Delaware corporation (the “Company”) and the Purchasers have entered into a Securities
Purchase Agreement and Securities Exchange Agreement, both dated as of March ___, 2017 (as amended, supplemented or otherwise
modified from time to time, collectively, the “Agreements”);

 

WHEREAS, in connection with the Agreements, the Subsidiaries of the Company (other than the Additional Guarantor) have entered
into the Subsidiary Guarantee, dated as of March __, 2017 (as amended, supplemented or otherwise modified from time to time, the
“Guarantee”) in favor of the Purchasers;

 

WHEREAS,
the Agreements require the Additional Guarantor to become a party to the Guarantee; and

 

WHEREAS,
the Additional Guarantor has agreed to execute and deliver this Assumption Agreement in order to become a party to the
Guarantee;

 

NOW, THEREFORE,
IT IS AGREED:

 

1.              
Guarantee. By executing and delivering this Assumption Agreement, the Additional Guarantor, as provided in Section 5(m)
of the Guarantee, hereby becomes a party to the Guarantee as a Guarantor thereunder with the same force and effect as if originally
named therein as a Guarantor and, without limiting the generality of the foregoing, hereby expressly assumes all obligations and
liabilities of a Guarantor thereunder. The information set forth in Annex 1 hereto is hereby added to the information set forth
in Schedule 1 to the Guarantee. The Additional Guarantor hereby represents and warrants that each of the representations and warranties
contained in Section 3 of the Guarantee is true and correct on and as the date hereof as to such Additional Guarantor (after giving
effect to this Assumption Agreement) as if made on and as of such date.

 

2.              
Governing Law. THIS ASSUMPTION AGREEMENT SHALL BE GOVERNED BY, AND CONSTRUED AND INTERPRETED IN ACCORDANCE WITH, THE LAW
OF THE STATE OF NEW YORK.

 

IN WITNESS
WHEREOF, the undersigned has caused this Assumption Agreement to be duly executed and delivered as of the date first above
written.

[ADDITIONAL GUARANTOR]

By:                                                                     

Name:

Title:

 

 

 

 

    	 	13Exhibit 10.131

 

EXCHANGE AGREEMENT

 

EXCHANGE AGREEMENT
(the “Agreement”) is made as of the 15th day of March 2017, by and between Rennova Health, Inc.,
a Delaware corporation (the “Company”), and the investor signatory hereto (the “Investor”).

 

WHEREAS, on
December 19, 2016, the Company issued registered shares of Series H Convertible Preferred Stock (“Series H Preferred
Stock”), par value $0.01 per share;

 

WHEREAS, on
the date hereof, the Investor owns 2,000 shares of Series H Preferred Stock, with an aggregate stated value of $2,000,000 (the
“Held Series H Preferred Stock”);

 

WHEREAS, on
February 2, 2017, the Company issued to the Investor an unregistered Original Issue Discount Convertible Debenture with a principal
amount equal to $1,590,000 (the “Bridge Debenture” and together with the Held Series H Preferred Stock,
the “Existing Securities” or “Securities”);

 

WHEREAS, subject
to the terms and conditions set forth in this Agreement and pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended
(the “Securities Act”), and in reliance on Section 3(a)(9) of the Securities Act, the Company desires
to exchange with the Investor, and the Investor desires to exchange with the Company, the Existing Securities for Senior Secured
Original Issue Discount Convertible Debentures (“Debenture”) and Common Stock Purchase Warrants (“Warrant”,
and together with the Debenture, the "Exchange Securities"); and

 

WHEREAS, the
Company and the Investor acknowledge that the issuance of certain shares of Common Stock underlying the Exchange Securities is
subject to the approval of the stockholders of the Company pursuant to the limitations imposed by the Nasdaq Stock Market,

 

NOW, THEREFORE,
for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, and in consideration of
the premises and the mutual agreements, representations and warranties, provisions and covenants contained herein, the parties
hereto, intending to be legally bound hereby, agree as follows:

 

1.                 
Exchange. On the Closing Date (as defined below), subject to the terms and conditions of this Agreement, the Investor
shall, and the Company shall, pursuant to Section 3(a)(9) of the Securities Act, exchange the Existing Securities for the Exchange
Securities. For each $0.80 of principal amount of Bridge Debenture or $1 of stated value of Held Series H Preferred Stock surrendered
to the Company, the Company shall issue to the Investor a Debenture with a principal amount of $1.24, along with three series of
Warrants. Debentures and Warrants will be in the form of the Senior Secured Original Issue Discount Convertible Debentures and
Common Stock Purchase Warrants issued pursuant to that certain Securities Purchase Agreement, dated as of the date hereof. The
Series A Warrant shall have a term of exercise of 5 years and be exercisable into a number of shares of Common Stock equal to 100%
of the number of shares underlying the Debenture. The Series B Warrant shall have a term of exercise of 18 months and be exercisable
into a number of shares of Common Stock equal to 100% of the number of shares underlying the Debenture. The Series C Warrant shall
have a term of exercise of 5 years and be exercisable into a number of shares of Common Stock equal to 100% of the number of shares
underlying the Debenture; provided that such Series C Warrant shall vest ratably upon exercise of the Series B Warrant. Subject
to the conditions set forth below, the Exchange shall take place at the offices of Ellenoff Grossman & Schole LLP, on the third
Trading Day (as defined below) after the date hereof, or at such other time and place as the Company and the Investor mutually
agree (the “Closing” and the “Closing Date”). At the Closing, the following
transactions shall occur (such transactions in this Section 1, the “Exchange”):

 

 

    	 	1	 

     

    

 

1.1             
On the Closing Date, in exchange for the Existing Securities, the Company shall deliver the Exchange Securities to the Investor
or its designee in accordance with the Investor’s delivery instructions set forth on the Investor signature page hereto.
Upon receipt of the Exchange Securities in accordance with this Section 1.1, all of the Investor’s rights under the Existing
Securities shall be extinguished. The Investor shall tender to the Company the Existing Securities within three Trading Days (as
defined below) of the Closing Date.

 

1.2             
On the Closing Date, the Investor shall be deemed for all corporate purposes to have become the holder of record of the
Exchange Securities, irrespective of the date such Exchange Securities are delivered to the Investor in accordance herewith. As
used herein, “Trading Day” means any day on which the Common Stock is traded on the NASDAQ Capital Market,
or, if the NASDAQ Capital Market is not the principal trading market for the Common Stock, then on the principal securities exchange
or securities market on which the Common Stock is then traded.

 

1.3             
The Company and the Investor shall execute and/or deliver such other documents and agreements as are customary and reasonably
necessary to effectuate the Exchange.

 

1.4             
The Company shall hold a special meeting of shareholders (which may also be at the annual meeting of shareholders) at the
earliest practical date, but in no event later than 60 days following the Closing Date (90 days in the event of a review of the
proxy statement), for the purpose of obtaining Shareholder Approval (as defined below), with the recommendation of the Company’s
Board of Directors that such proposal be approved, and the Company shall solicit proxies from its shareholders in connection therewith
in the same manner as all other management proposals in such proxy statement and all management-appointed proxyholders shall vote
their proxies in favor of such proposal. The Company shall use best efforts to obtain Shareholder Approval. If the Company does
not obtain Shareholder Approval at the first meeting, the Company shall call a meeting every four months thereafter to seek Shareholder
Approval until the earlier of the date on which Shareholder Approval is obtained or the Debentures are no longer outstanding. “Shareholder
Approval” means such approval as may be required by the applicable rules and regulations of the Nasdaq Stock Market
(or any successor entity) from the shareholders of the Company with respect to the transactions contemplated by the Transaction
Documents, including the issuance of all of the shares of Common Stock underlying the Debentures and Warrants issued hereunder
in excess of 19.99% of the issued and outstanding Common Stock on the Closing Date. The Company shall file the preliminary proxy
for Shareholder Approval within 15 days of the Closing Date.

 

 

 

 

    	 	2	 

     

    

 

2.                 
Closing Conditions.

 

2.1             
Conditions to Investor’s Obligations. The obligation of the Investor to consummate the Exchange is subject
to the fulfillment, to the Investor’s reasonable satisfaction, prior to or at the Closing, of each of the following conditions:

 

(a)              
Representations and Warranties. The representations and warranties of the Company contained in this Agreement shall
be true and correct in all material respects on the date hereof and on and as of the Closing Date as if made on and as of such
date.

 

(b)              
Issuance of Securities. At the Closing, the Company shall issue the Exchange Securities on the books and records
of the Company as follows:

 

(i)                
a Debenture with a principal amount equal to 1.24 times such Investor’s principal amount of Bridge Debentures, registered
in the name of such Investor with monthly amortizations commencing on the earlier of (1) June 1, 2017 and (2) the effective date
of the registration statement registering for resale the shares underlying such Debenture;

 

(ii)             
a Debenture with a principal amount equal to 1.24 times such Investor’s stated value of Series H Preferred Stock,
registered in the name of such Investor with monthly amortizations commencing on March 20, 2017;

 

(iii)           
a Series A Warrant registered in the name of such Investor to purchase up to a number of shares of Common Stock equal to
100% of such Investor’s aggregate principal amount of Debentures as set forth on the signature pages hereto divided by $1.66,
with an exercise price equal to $1.95 subject to adjustment therein;

 

(iv)            
a Series B Warrant registered in the name of such Investor to purchase up to a number of shares of Common Stock equal to
100% of such Investor’s aggregate principal amount of Debentures as set forth on the signature pages hereto divided by $1.66,
with an exercise price equal to $1.66, subject to adjustment therein;

 

(v)              
a Series C Warrant registered in the name of such Investor to purchase up to a number of shares of Common Stock equal to
100% of such Investor’s aggregate principal amount of Debentures as set forth on the signature pages hereto divided by $1.66,
with an exercise price equal to $1.95, subject to adjustment therein;

 

(c)              
No Actions. No action, proceeding, investigation, regulation or legislation shall have been instituted, threatened
or proposed before any court, governmental agency or authority or legislative body to enjoin, restrain, prohibit or obtain substantial
damages in respect of, this Agreement or the consummation of the transactions contemplated by this Agreement.

 

 

 

 

 

 

    	 	3	 

     

    

 

(d)              
Proceedings and Documents. All proceedings in connection with the transactions contemplated hereby and all documents
and instruments incident to such transactions shall be satisfactory in substance and form to the Investor, and the Investor shall
have received all such counterpart originals or certified or other copies of such documents as they may reasonably request.

 

(e)              
Registration Rights Agreement. The Company and the Investor shall have entered into a registration rights agreement
in form and substance satisfactory to the Investor.

 

(f)               
Listing of Exchange Securities. The Company shall have secured the listing or designation for quotation (as applicable)
of all of the shares of Common Stock underlying the Debentures, upon each national securities exchange and automated quotation
system, if any, upon which the shares underlying the Debentures are then listed or designated for quotation (as applicable).

 

(g)              
Security Agreement, Subsidiary Guarantee and UCC Filings. The Company and the Investor shall have entered into a
Security Agreement, duly executed by the Company and each Subsidiary, along with subsidiary guarantees from each subsidiary of
the Company, a pledge along with pledge securities from each subsidiary and all UCC-1 filings, all in form and substance satisfactory
to the Investor.

 

(h)              
Voting Agreements. The Company shall have provided voting agreements of all officers and directors of the Company
to vote in favor of the Shareholder Approval.

 

(i)                
Opinion. An opinion of Company counsel in form and substance reasonably satisfactory to the Investor.

 

(j)                
Subordination Agreement. The Company shall have delivered duly executed subordination agreements from the subordinated
creditors of the Company, dated on or about the date hereof, in form and substance acceptable to the Investor.

 

2.2             
Conditions to the Company’s Obligations. The obligation of the Company to consummate the Exchange is subject
to the fulfillment, to the Company’s reasonable satisfaction, prior to or at the Closing, of each of the following conditions:

 

(a)              
Representations and Warranties. The representations and warranties of the Investor contained in this Agreement shall
be true and correct in all material respects on the date hereof and on and as of the Closing Date as if made on and as of such
date.

 

(b)              
No Actions. No action, proceeding, investigation, regulation or legislation shall have been instituted, threatened
or proposed before any court, governmental agency or authority or legislative body to enjoin, restrain, prohibit, or obtain substantial
damages in respect of, this Agreement or the consummation of the transactions contemplated by this Agreement.

 

 

 

 

 

    	 	4	 

     

    

 

(c)              
Proceedings and Documents. All proceedings in connection with the transactions contemplated hereby and all documents
and instruments incident to such transactions shall be satisfactory in substance and form to the Company and the Company shall
have received all such counterpart originals or certified or other copies of such documents as the Company may reasonably request.

 

3.                 
Representations and Warranties of the Company. The Company hereby represents and warrants to Investor that:

 

3.1             
Organization, Good Standing and Qualification. The Company is a corporation duly organized, validly existing and
in good standing under the laws of the State of Delaware. The Company is duly qualified to transact business and is in good standing
in each jurisdiction in which the failure to so qualify would have a material adverse effect on its business or properties.

 

3.2             
Authorization. Other than the Shareholder Approval, all corporate action on the part of the Company, its officers,
directors and stockholders necessary for the authorization, execution and delivery of this Agreement and the performance of all
obligations of the Company hereunder, and the authorization (or reservation for issuance of), the Exchange, and the issuance of
the Exchange Securities and the shares of Common Stock issuable upon conversion or exercise of the Exchange Securities have been
taken on or prior to the date hereof.

 

3.3             
Valid Issuance of the Securities. The Debentures, Warrants and shares of Common Stock issuable upon conversion or
exercise thereof, as applicable, when issued and delivered in accordance with the terms of this Agreement, for the consideration
expressed herein, will be duly and validly issued, fully paid and nonassessable. Subject to the truth and accuracy of the Investor’s
representations set forth in Section 5 of this Agreement, the Exchange Securities issued in exchange for the Series H Preferred
Stock and the shares of Common Stock issuable thereunder (assuming cashless exercise of the applicable Warrants) are freely tradeable
without the need for registration under the Securities Act and shall not be required to bear any Securities Act legend.

 

3.4             
Offering. Subject to the truth and accuracy of the Investor’s representations set forth in Section 5 of this
Agreement, the offer and issuance of the Securities as contemplated by this Agreement are exempt from the registration requirements
of the Securities Act. Neither the Company nor any authorized agent acting on its behalf will take any action hereafter that would
cause the loss of such exemptions.

 

3.5             
Compliance With Laws. The Company has not violated any law or any governmental regulation or requirement which violation
has had or would reasonably be expected to have a material adverse effect on its business, and the Company has not received written
notice of any such violation.

 

3.6             
Consents; Waivers. Other than the Shareholder Approval, no consent, waiver, approval or authority of any nature,
or other formal action, by any Person, not already obtained, is required in connection with the execution and delivery of this
Agreement by the Company or the consummation by the Company of the transactions provided for herein and therein.

 

 

 

 

 

    	 	5	 

     

    

 

3.7             
Acknowledgment Regarding Investor’s Purchase of Securities. The Company acknowledges and agrees that the Investor
is acting solely in the capacity of arm’s length Investor with respect to this Agreement and the other documents entered
into in connection herewith (collectively, the “Transaction Documents”) and the transactions contemplated
hereby and thereby and that the Investor is not (i) an officer or director of the Company, (ii) an “affiliate” of the
Company (as defined in Rule 144 promulgated under the Securities Act), or (iii) to the knowledge of the Company, a “beneficial
owner” of more than 10% of the shares of Common Stock (as defined for purposes of Rule 13d-3 of the Securities Exchange Act
of 1934, as amended). The Company further acknowledges that the Investor is not acting as a financial advisor or fiduciary of the
Company (or in any similar capacity) with respect to the Transaction Documents and the transactions contemplated hereby and thereby,
and any advice given by the Investor or any of its representatives or agents in connection with the Transaction Documents and the
transactions contemplated hereby and thereby is merely incidental to the Investor’s acceptance of the Exchange Securities.
The Company further represents to the Investor that the Company’s decision to enter into the Transaction Documents has been
based solely on the independent evaluation by the Company and its representatives.

 

3.8             
Absence of Litigation. There is no action, suit, proceeding, inquiry or investigation before or by any court, public
board, government agency, selfregulatory organization or body pending or, to the knowledge of the Company, threatened against or
affecting the Company, the Securities or any of the Company’s officers or directors in their capacities as such.

 

3.9             
No Group. The Company acknowledges that, to the Company’s knowledge, the Investor is acting independently in
connection with this Agreement and the transactions contemplated hereby, and is not acting as part of a “group” as
such term is defined under Section 13(d) of the Securities Act and the rules and regulations promulgated thereunder.

 

3.10         
Validity; Enforcement; No Conflicts. This Agreement and each Transaction Document to which the Company is a party
have been duly and validly authorized, executed and delivered on behalf of the Company and shall constitute the legal, valid and
binding obligations of the Company enforceable against the Company in accordance with their respective terms, except as such enforceability
may be limited by general principles of equity or to applicable bankruptcy, insolvency, reorganization, moratorium, liquidation
and other similar laws relating to, or affecting generally, the enforcement of applicable creditors’ rights and remedies.
The execution, delivery and performance by the Company of this Agreement and each Transaction Document to which the Company is
a party and the consummation by the Company of the transactions contemplated hereby and thereby will not (i) result in a violation
of the organizational documents of the Company or (ii) conflict with, or constitute a default (or an event which with notice or
lapse of time or both would become a default) under, or give to others any rights of termination, amendment, acceleration or cancellation
of, any agreement, indenture or instrument to which the Company is a party or by which it is bound, or (iii) result in a violation
of any law, rule, regulation, order, judgment or decree (including federal and state securities or “blue sky” laws)
applicable to the Company, except in the case of clause (ii) above, for such conflicts, defaults or rights which would not, individually
or in the aggregate, reasonably be expected to have a material adverse effect on the ability of the Company to perform its obligations
hereunder.

 

 

 

 

 

 

    	 	6	 

     

    

 

3.11         
Disclosure. The Company confirms that neither it nor any other Person acting on its behalf has provided the Investor
or its agents or counsel with any information that constitutes or could reasonably be expected to constitute material, nonpublic
information. The Company understands and confirms that the Investor will rely on the foregoing representations in effecting transactions
in the Exchange Securities.

 

3.12         
Bring-Down of Representations and Warranties. All representations
and warranties made by the Company to the Holder in any prior agreements pursuant to which the Exchange Securities were originally
issued are accurate and complete in all material respects as of the date hereof, unless as of a specific date therein in which
case they shall be accurate as of such date (or, to the extent representations or warranties are qualified by materiality or Material
Adverse Effect (as defined in such agreements), in all respects).

 

4.                 
Representations and Warranties of the Investor. The Investor hereby represents, warrants and covenants that:

 

4.1             
Authorization. The Investor has full power and authority to enter into this Agreement, to perform its obligations
hereunder and to consummate the transactions contemplated hereby and has taken all action necessary to authorize the execution
and delivery of this Agreement, the performance of its obligations hereunder and the consummation of the transactions contemplated
hereby.

 

4.2             
Accredited Investor Status; Investment Experience. The Investor is an “accredited investor” as that
term is defined in Rule 501(a) of Regulation D. The Investor can bear the economic risk of its investment in the Securities, and
has such knowledge and experience in financial and business matters that it is capable of evaluating the merits and risks of an
investment in the Securities.

 

4.3             
Reliance on Exemptions. The Investor understands that the Securities are being offered and issued to it in reliance
on specific exemptions from the registration requirements of United States federal and state securities laws and that the Company
is relying in part upon the truth and accuracy of, and the Investor’s compliance with, the representations, warranties, agreements,
acknowledgments and understandings of the Investor set forth herein in order to determine the availability of such exemptions and
the eligibility of the Investor to acquire the Securities.

 

4.4             
Information. The Investor and its advisors, if any, have been furnished with all materials relating to the business,
finances and operations of the Company and materials relating to the offer and issuance of the Securities which have been requested
by the Investor. The Investor has had the opportunity to review the Company's filings with the Securities and Exchange Commission.
The Investor and its advisors, if any, have been afforded the opportunity to ask questions of the Company. Neither such inquiries
nor any other due diligence investigations conducted by the Investor or its advisors, if any, or its representatives shall modify,
amend or affect the Investor’s right to rely on the Company’s representations and warranties contained herein. The
Investor understands that its investment in the Securities involves a high degree of risk. The Investor has sought such accounting,
legal and tax advice as it has considered necessary to make an informed investment decision with respect to its acquisition of
the Securities. The Investor is relying solely on its own accounting, legal and tax advisors, and not on any statements of the
Company or any of its agents or representatives, for such accounting, legal and tax advice with respect to its acquisition of the
Securities and the transactions contemplated by this Agreement.

 

 

 

 

 

    	 	7	 

     

    

 

4.5             
No Governmental Review. The Investor understands that no United States federal or state agency or any other government
or governmental agency has passed on or made any recommendation or endorsement of the Securities or the fairness or suitability
of the investment in the Securities nor have such authorities passed upon or endorsed the merits of the offering of the Securities.

 

4.6             
Validity; Enforcement; No Conflicts. This Agreement and each Transaction Document to which the Investor is a party
have been duly and validly authorized, executed and delivered on behalf of the Investor and shall constitute the legal, valid and
binding obligations of the Investor enforceable against the Investor in accordance with their respective terms, except as such
enforceability may be limited by general principles of equity or to applicable bankruptcy, insolvency, reorganization, moratorium,
liquidation and other similar laws relating to, or affecting generally, the enforcement of applicable creditors’ rights and
remedies. The execution, delivery and performance by the Investor of this Agreement and each Transaction Document to which the
Investor is a party and the consummation by the Investor of the transactions contemplated hereby and thereby will not (i) result
in a violation of the organizational documents of the Investor or (ii) conflict with, or constitute a default (or an event which
with notice or lapse of time or both would become a default) under, or give to others any rights of termination, amendment, acceleration
or cancellation of, any agreement, indenture or instrument to which the Investor is a party, or (iii) result in a violation of
any law, rule, regulation, order, judgment or decree (including federal and state securities or “blue sky” laws) applicable
to the Investor, except in the case of clause (ii) above, for such conflicts, defaults or rights which would not, individually
or in the aggregate, reasonably be expected to have a material adverse effect on the ability of the Investor to perform its obligations
hereunder.

 

4.7              Ownership
of Bridge Debentures and Series H Preferred Stock. The Investor owns and holds, beneficially and of record, the entire
right, title, and interest in and to the Bridge Debentures and Series H Preferred Stock set forth on the signature
page hereto free and clear of all rights and Liens (as defined below). The Investor has full power and authority to transfer
and dispose of the Bridge Debentures and Series H Preferred Stock to the Company free and clear of any right or Lien. Other
than the transactions contemplated by this Agreement, there is no outstanding vote, plan, pending proposal, or other right,
of any Person to acquire all or any part of the Bridge Debentures, the Series H Preferred Stock or any shares of Common Stock
issuable upon exercise of the Bridge Debentures or conversion of the Series H Preferred Stock. As used herein,
“Liens” shall mean any security or other property interest or right, claim, lien, pledge, option,
charge, security interest, contingent or conditional sale, or other title claim or retention agreement, interest or other
right or claim of third parties, whether perfected or not perfected, voluntarily incurred or arising by operation of law, and
including any agreement (other than this Agreement) to grant or submit to any of the foregoing in the future.

 

 

 

 

 

 

    	 	8	 

     

    

 

4.8             
No Consideration Paid. No commission or other remuneration has been paid by the Investor (or any of its agents or
affiliates) to the Company related to the Exchange.

 

5.                 
Additional Covenants.

 

5.1             
Disclosure. The Company shall, on or before 9:30 a.m., New York City time, on the first business day after the date
of this Agreement, issue a Current Report on Form 8-K (collectively, the “8-K Filing”) disclosing all
material terms of the transactions contemplated hereby. From and after the issuance of the 8-K Filing, the Investor shall not be
in possession of any material, nonpublic information received from the Company or any of its respective officers, directors, employees
or agents, that is not disclosed in the 8-K Filing. The Company shall not, and shall cause its officers, directors, employees and
agents, not to, provide the Investor with any material, nonpublic information regarding the Company from and after the filing of
the 8-K Filing without the express written consent of the Investor. The Company shall not disclose the name of the Investor in
any filing, announcement, release or otherwise, unless such disclosure is required by law or regulation. In addition, effective
upon the filing of the 8-K Filing, the Company acknowledges and agrees that any and all confidentiality or similar obligations
under any agreement, whether written or oral, between the Company, any of its subsidiaries or any of their respective officers,
directors, affiliates, employees or agents, on the one hand, and the Investor or any of its affiliates, on the other hand, shall
terminate.

 

5.2             
Listing. The Company shall use its best efforts to maintain the listing or designation for quotation (as applicable)
of all of the shares of Common Stock underlying the Debentures and Warrants upon each national securities exchange and automated
quotation system on which the Common Stock is currently listed or designated while such securities are outstanding. The Company
shall pay all fees and expenses in connection with satisfying its obligations under this Section 6.2.

 

5.3             
Registered Characteristics. Subject to the truth and accuracy of the Investor’s representations set forth in
Section 4 of this Agreement, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the Securities Act, the
Exchange Securities (assuming cashless exercise of the Warrants) issued in Exchange for the Series H Preferred Stock take on the
registered characteristics of the Series H Preferred Stock and the Company agrees not to take a position to the contrary. Upon
conversion of such Debentures and exercise of such Warrants (assuming cashless exercise) the shares issuable thereunder shall be
freely tradeable and free of any restrictions on resale or Securities Act legends.

 

5.4             
Tacking. Subject to the truth and accuracy of the Investor’s representations set forth in Section 4 of this
Agreement, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the Securities Act, the Exchange Securities
(assuming cashless exercise of the Warrants) issued in Exchange for the Bridge Debentures will tack back to the original issue
date of such Bridge Debentures pursuant to Rule 144 and the Company agrees not to take a position to the contrary.

 

 

 

 

 

 

 

 

    	 	9	 

     

    

 

5.5             
Survival of Covenants. Sections 4.1, 4.3, 4.5, 4.6, 4.8, 4.10, 4.11, 4.12 (subject to the limitations set forth in
that certain Securities Purchase Agreement dated as of the date hereof with the Company, the Investor and certain other investors
signatory thereto), 4.13(b) and 4.15 of that certain Securities Purchase Agreement dated as of January 29, 2017 shall survive and
be incorporated by reference into this Agreement and Debentures, Warrants and the shares underlying the Debentures and Warrants
issuable hereunder shall for all such purposes be deemed “Debentures”, “Warrants”, “Securities”,
“Conversion Shares”, “Warrant Shares” and “Underlying Shares” as applicable and as used under
such Securities Purchase Agreement as if the Debentures and Warrants were issued pursuant to such agreement.

 

5.6             
Blue Sky. The Company shall make all filings and reports relating to the Exchange required under applicable securities
or “Blue Sky” laws of the states of the United States following the date hereof, if any.

 

5.7             
Fees and Expenses. Each party shall pay the fees and expenses of its advisers, counsel, accountants and other experts,
if any, and all other expenses incurred by such party incident to the negotiation, preparation, execution, delivery and performance
of this Agreement.

 

6.                 
Miscellaneous.

 

6.1             
Successors and Assigns. Except as otherwise provided herein, the terms and conditions of this Agreement shall inure
to the benefit of and be binding upon the parties hereto and the respective successors and assigns of the parties. Nothing in this
Agreement, express or implied, is intended to confer upon any party, other than the parties hereto or their respective successors
and assigns, any rights, remedies, obligations or liabilities under or by reason of this Agreement, except as expressly provided
in this Agreement.

 

6.2             
Governing Law; Jurisdiction; Jury Trial. All questions concerning the construction, validity, enforcement and interpretation
of this Agreement shall be governed by the internal laws of the State of New York, without giving effect to any choice of law or
conflict of law provision or rule (whether of the State of New York or any other jurisdictions) that would cause the application
of the laws of any jurisdictions other than the State of New York. Each party hereby irrevocably submits to the exclusive jurisdiction
of the state or federal courts sitting in The City of New York, Borough of Manhattan, for the adjudication of any dispute hereunder
or in connection herewith or with any transaction contemplated hereby or discussed herein, and hereby irrevocably waives, and agrees
not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of any such court,
that such suit, action or proceeding is brought in an inconvenient forum or that the venue of such suit, action or proceeding is
improper. Each party hereby irrevocably waives personal service of process and consents to process being served in any such suit,
action or proceeding by mailing a copy thereof to such party at the address for such notices to it under this Agreement and agrees
that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be
deemed to limit in any way any right to serve process in any manner permitted by law. EACH PARTY HEREBY IRREVOCABLY WAIVES ANY
RIGHT IT MAY HAVE, AND AGREES NOT TO REQUEST, A JURY TRIAL FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION WITH
OR ARISING OUT OF THIS AGREEMENT OR ANY TRANSACTION CONTEMPLATED HEREBY.

 

 

 

 

 

    	 	10	 

     

    

 

6.3             
Titles and Subtitles. The titles and subtitles used in this Agreement are used for convenience only and are not to
be considered in construing or interpreting this Agreement.

 

6.4             
Notices. Any notices, consents, waivers or other communications required or permitted to be given under the terms
of this Agreement must be in writing and will be deemed to have been delivered: (i) upon receipt, when delivered personally; (ii)
upon receipt, when sent by facsimile (provided confirmation of transmission is mechanically or electronically generated and kept
on file by the sending party) or by electronic mail; or (iii) one Business Day after deposit with an overnight courier service,
in each case properly addressed to the party to receive the same. The addresses, facsimile numbers and email addresses for such
communications shall be:

 

If to the Company:

 

Rennova Health, Inc.

400 South Australian Avenue, 8th
Floor

West Palm Beach, Florida 33401

Attention: Chief Executive Officer

Telephone: (561) 855-1626

Facsimile: (561) 282-3417

E-mail: slagan@rennovahealth.com

 

With a copy to:

 

Shutts & Bowen LLP

200 South Biscayne Boulevard, Suite
4100

Miami, FL 33131

Telephone: (305) 379-9141

Facsimile: (305) 347-7767

Email: TCookson@shutts.com

 

If to the Investor,
to its address, facsimile number and email address set forth on its signature page hereto,

 

or to such other address, facsimile number
and/or email address and/or to the attention of such other Person as the recipient party has specified by written notice given
to each other party five (5) days prior to the effectiveness of such change. Written confirmation of receipt (A) given by the recipient
of such notice, consent, waiver or other communication, (B) mechanically or electronically generated by the sender’s facsimile
machine or email containing the time, date, recipient facsimile number and an image of the first page of such transmission or (C)
provided by an overnight courier service shall be rebuttable evidence of personal service, receipt by facsimile or receipt from
an overnight courier service in accordance with clause (i), (ii) or (iii) above, respectively.

 

 

 

 

    	 	11	 

     

    

 

6.5             
Finder’s Fees. Each party represents that it neither is nor will be obligated for any finders’ fee or
commission in connection with this transaction. The Investor shall indemnify and hold harmless the Company from any liability for
any commission or compensation in the nature of a finders’ fee (and the costs and expenses of defending against such liability
or asserted liability) for which the Investor or any of its officers, partners, employees or representatives is responsible. The
Company shall indemnify and hold harmless the Investor from any liability for any commission or compensation in the nature of a
finders’ fee (and the costs and expenses of defending against such liability or asserted liability) for which the Company
or any of its officers, employees or representatives is responsible.

 

6.6             
Amendments and Waivers. Any term of this Agreement may be amended and the observance of any term of this Agreement
may be waived (either generally or in a particular instance and either retroactively or prospectively), only with the written consent
of the Company and the Investor. Any amendment or waiver effected in accordance with this paragraph shall be binding upon Investor
and the Company, provided that no such amendment shall be binding on a holder that does not consent thereto to the extent such
amendment treats such party differently than any party that does consent thereto.

 

6.7             
Severability. If one or more provisions of this Agreement are held to be unenforceable under applicable law, such
provision shall be excluded from this Agreement and the balance of the Agreement shall be interpreted as if such provision were
so excluded and shall be enforceable in accordance with its terms.

 

6.8             
Entire Agreement. This Agreement represents the entire agreement and understanding between the parties concerning
the Exchange and the other matters described herein and therein and supersedes and replaces any and all prior agreements and understandings
solely with respect to the subject matter hereof and thereof.

 

6.9             
Counterparts. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original,
but all of which together shall constitute one and the same instrument.

 

6.10         
Interpretation. Unless the context of this Agreement clearly requires otherwise, (a) references to the plural include
the singular, the singular the plural, the part the whole, (b) references to any gender include all genders, (c) “including”
has the inclusive meaning frequently identified with the phrase “but not limited to” and (d) references to “hereunder”
or “herein” relate to this Agreement.

 

6.11         
No Third Party Beneficiaries. This Agreement is intended for the benefit of the parties hereto and their respective
permitted successors and assigns, and is not for the benefit of, nor may any provision hereof be enforced by, any other Person.

 

6.12         
Survival. The representations, warranties and covenants of the Company and the Holder contained herein shall survive
the Closing and delivery of the Securities.

 

6.13         
Further Assurances. Each party shall do and perform, or cause to be done and performed, all such further acts and
things, and shall execute and deliver all such other agreements, certificates, instruments and documents, as any other party may
reasonably request in order to carry out the intent and accomplish the purposes of this Agreement and the consummation of the transactions
contemplated hereby.

 

6.14         
No Strict Construction. The language used in this Agreement will be deemed to be the language chosen by the parties
to express their mutual intent, and no rules of strict construction will be applied against any party.

 

[SIGNATURES
ON THE FOLLOWING PAGES]

 

 

 

 

 

 

    	 	12	 

     

    

 

IN WITNESS WHEREOF,
the parties have caused this Agreement to be duly executed and delivered as of the date provided above.

 

THE   COMPANY

 

RENNOVA HEALTH, INC.

 

By: /s/ Seamus Lagan       

Name: Seamus Lagan          

Title: Chief Executive Officer          

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    	 	13	 

     

    

 

IN WITNESS WHEREOF,
the parties have caused this Agreement to be duly executed and delivered as of the date provided above.

 

INVESTOR

 

 

Name of Investor: Sabby Healthcare
Master Fund, Ltd.                                        

 

Signature of Authorized Signatory of
Investor: /s/ Robert Grundstein     

 

Name of Authorized Signatory: Robert
Grundstein     

 

Title of Authorized Signatory: COO
of Purchaser’s Investment Manager     

 

Email Address of Authorized Signatory:
rgrundstein@sabbycapital.com     

 

Facsimile Number of Authorized Signatory: 201-661-8654          

 

Address for Notice to Investor: c/o Sabby Management,
LLC, 10 Mountainview Road, Suite 205, Upper Saddle River, New Jersey 07548

 

 

 

 

Address for Delivery of Securities to Investor (if not same
as address for notice):

 

 

 

Bridge Debentures Surrendered: $1,987,500     

 

Stated Value of Series H Preferred Stock
Surrendered: $2,000,000     

 

First Debenture (1.24 x principal amount
of Bridge Debenture): 2,464,500     

 

Second Debenture (1.24 x stated value
of Series H): 2,480,000     

 

Series A Warrant Shares: 2,978,614     

 

Series B Warrant Shares: 2,978,614     

 

Series C Warrant Shares: 2,978,614     

 

[SIGNATURE PAGES CONTINUE]

 

 

 

 

 

 

 

 

    	 	14

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00268-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00268-of-00352.parquet"}]]